We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Global COVID-19 Antigen Test Market to Continue Being Driven by Evolution of New SARS-CoV-2 Strains

By LabMedica International staff writers
Posted on 22 Sep 2021
Print article
The global COVID-19 antigen test market is witnessing increasing demand due to the evolution of new strains of the SARS-CoV-2 virus and increasing spikes in the instances of new COVID-19 infections.

These are the latest findings of Transparency Market Research (Albany, NY, USA), a next-generation market intelligence provider.

Products in the global COVID-19 antigen test market are expected to gain traction owing to their benefits such as shorter test-to-result timeline, as well as their patient-friendly and easy-to-use nature. Furthermore, scalability and timeline challenges regarding PCR testing for the SARS-CoV-2 virus are among the major factors resulting in increased uptake of products in the global COVID-19 antigen test market. Moreover, the emergence of several COVID-19 variants in countries such as Brazil, the UK, and South Africa has intensified the requirement for enhanced and rapid testing products, thus fueling the growth of the global COVID-19 antigen test market. Increasing concerns over the frequency as well as spread of these variants are also anticipated to favor the expansion of the global COVID-19 antigen test market. Furthermore, increased demand for low cost rapid test kits for conducting large scale testing in order to control the spike in COVID-19 cases in various underdeveloped economies is also expected to favor the expansion of the global COVID-19 antigen test market over the coming years.

Additionally, the rising number of product approvals as well as emergency use authorizations by regulatory bodies, coupled with various technological collaborations between several operating entities, is expected to intensify the competitive landscape of the global COVID-19 antigen test market, going forward. Geographically, Asia Pacific is anticipated to account for the largest share of the global COVID-19 antigen test market in terms of revenue, mainly due to the strong presence of various regional and local players who are actively innovating newer antigen tests, as well as the introduction of various new products by several up and coming start-ups in the region.

Related Links:

Transparency Market Research

Gold Supplier
Nucleic Acid Detection Kit For COVID-19 (PCR Fluorescence Probe)
Nucleic Acid Detection Kit For COVID-19 (PCR Fluorescence Probe)
Gold Supplier
Fully Automated Batch Immunoanalyzer
Real Time PCR Platform
6-Channel Viscoelastometry Analyzer

Print article


Molecular Diagnostics

view channel
Image: A cancer cell during cell division (Photo courtesy of [U.S.] National Institutes of Health)

New Method Promises Rapid Isolation of Biomarker-Rich Extracellular Vesicles

A new method for isolating and analyzing cancer biomarkers from extracellular vesicles present in biological fluids is based on a novel magnetic particle based liquid biopsy chip. Extracellular vesicles... Read more


view channel
Image: Colored Transmission electron micrograph of Clostridium difficile bacterium forming an endospore (lower right, red oval). Clostridium difficile produce a toxin that irritates the colon and causes diarrhea (Photo courtesy of Kari Lounatmaa, PhD)

Quantity of Toxin in Stool Correlates with C. difficile Severity

Clostridioides difficile (syn. Clostridium difficile), also known as C. difficile, or C. diff are Gram-positive species of spore-forming bacteria. Clostridioides spp. are anaerobic, motile bacteria, ubiquitous... Read more


view channel
Image: Non-Invasive Nasal Swab Test Leverages Advanced Genomic Technology to Detect Lung Cancer Risk (Photo courtesy of Veracyte, Inc.)

Non-Invasive Nasal Swab Test Leverages Advanced Genomic Technology to Detect Lung Cancer Risk

A novel, non-invasive nasal swab test could support more timely and accurate lung nodule diagnosis. Veracyte, Inc. (South San Francisco, CA, USA) has announced that new expanded clinical validation data... Read more


view channel
Image: VSE Cat. No. 84800 with optional mobile table and phenolic work surface (Photo courtesy of HEMCO Corporation)

Hemco Offers VSE Balance Enclosure for Critical Procedures Involving Powders and Liquids

HEMCO Corporation (Independence, MO, USA) is offering its Vented Safety Enclosure (VSE) in 24-, 36- and 48-inch widths to accommodate an analytical balance and other small-scale lab processes.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.